Literature DB >> 15245366

CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function.

S Russell1.   

Abstract

In the last 10 years, the human cell-surface molecule, CD46, has evolved from 'just another complement regulator' to a receptor for a striking array of pathogens. CD46 not only protects cells from complement-mediated attack and facilitates infection by a large number of pathogens, but also exerts complex effects on cellular immune function. It has been proposed that CD46 links innate and adaptive immunity by affecting cellular immune function in response to complement binding, and the role of CD46 in the pathogenesis of many infectious pathogens is now the subject of intense investigation. So far, the flood of information that implicates CD46 in modifying a host response to measles, Neisseria, human herpes virus 6, and pathogens that activate complement has not yet been matched with a comprehensive understanding of the molecular mechanisms by which CD46 affects immune function. This review summarizes the evidence that points to a significant role for CD46 in a range of pathological processes and describes how CD46 might exert its effects by altering signal transduction and antigen presentation pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245366     DOI: 10.1111/j.1399-0039.2004.00277.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  20 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.

Authors:  Christoph Fleischli; Sandra Verhaagh; Menzo Havenga; Dominique Sirena; Walter Schaffner; Roberto Cattaneo; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation.

Authors:  Jane Oliaro; Anupama Pasam; Nigel J Waterhouse; Kylie A Browne; Mandy J Ludford-Menting; Joseph A Trapani; Sarah M Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 4.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

5.  The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein).

Authors:  J A Cummerson; B F Flanagan; D G Spiller; P M Johnson
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

Review 6.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

7.  Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.

Authors:  Anne L Astier; Gregory Meiffren; Samuel Freeman; David A Hafler
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

Review 8.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

9.  Abnormal Tr1 differentiation in multiple sclerosis.

Authors:  Anne L Astier; David A Hafler
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

Review 10.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.